Y-MABS THERAPEUTICS INC shareholders Q3 2023

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
METROPOLITAN LIFE INSURANCE CO/NY 2,055$11,2000.00%
MILLENNIUM MANAGEMENT LLC 346,916$1,890,6920.00%
SG Americas Securities, LLC 18,349$1000.00%
MARSHALL WACE, LLP 98,931$539,1750.00%
ExodusPoint Capital Management, LP 14,126$770.00%
HighMark Wealth Management LLC 220$1,1990.00%
Allspring Global Investments Holdings, LLC 6,484$35,3370.00%
FMR LLC 36,075$196,6090.00%
DIMENSIONAL FUND ADVISORS LP 241,589$1,316,6610.00%
FRANKLIN RESOURCES INC 15,679$85,4510.00%
VOYA INVESTMENT MANAGEMENT LLC 38,370$209,1170.00%
Eagle Bay Advisors LLC 50$2730.00%
BANK OF AMERICA CORP /DE/ 34,436$187,6760.00%
SIMPLEX TRADING, LLC 813$40.00%
Russell Investments Group, Ltd. 26,653$145,2580.00%
WELLS FARGO & COMPANY/MN 8,231$44,8590.00%
NORTHERN TRUST CORP 323,187$1,761,3700.00%
AMERICAN CENTURY COMPANIES INC 21,761$118,5970.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 15,582$84,9220.00%
External links

This page lists Y-MABS THERAPEUTICS INC's shareholders in Q3 2023. To view Y-MABS THERAPEUTICS INC's shareholder history, click here.